(1997; 248 pages) [French]
6. Exchange of evaluation reports
When a company applies for marketing authorization in more than one country, the exchange of evaluation reports between drug regulatory authorities on the same product from the same manufacturer can accelerate sound decision-making at the national level. Such an exchange should take place only subject to the agreement of the company concerned. Appropriate measures for safeguarding data confidentiality must be taken.